Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interfant-06 for infants with acute lymphoblastic or biphenotypic leukemia
2005-004599-19Phase 3Completed
- Sponsor
- Italian Association of Pediatric Hematology and Oncology
- Start
- May 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cytarabine, daunorubicin, etoposide, methotrexate, vincristine and 9 more in acute lymphoblastic leukemia (ALL) and Acute Leukaemia (3 arms), sponsored by Italian Association of Pediatric Hematology and Oncology. Primary endpoint: Disease-free survival. Started May 2007; status: completed.
02
Drugs
cytarabinedaunorubicinetoposidemethotrexatevincristine
03
Conditions
acute lymphoblastic leukemia (ALL)Acute Leukaemia
Beyond the preview
Go deeper on 2005-004599-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004599-19.